The European Commission is adjusting its sustainability reporting rules, easing the administrative burden on companies. Bio-pharma company UCB is seizing…
Read More

The European Commission is adjusting its sustainability reporting rules, easing the administrative burden on companies. Bio-pharma company UCB is seizing…
Read More
UCB relocated to raise Tk700cr via rights shares to expand operations, but hasn’t received BSEC approval in 4 months 20…
Read More